Prevent Reuse of Glucose Monitoring Devices

PUBLISHED: Dec 15, 2017
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Long Term Care, Medical Office/Clinic

The Joint Commission recently published a Quick Safety Issue addressing the reuse of glucose monitoring devices. The Centers for Disease Control and Prevention (CDC), the Centers for Medicare & Medicaid Services (CMS), and the U.S. Food and Drug Administration (FDA) all prohibit the reuse of lancets, fingerstick devices, and manufacturer-stated single-patient-use blood glucose meters. Reuse of these devices on multiple patients increases the risk of transmitting bloodborne pathogens such as hepatitis B, hepatitis C, and HIV viruses.

Within the Quick Safety Issue is guidance from TJC that includes the following:

  • Single use devices such as lancets or fingersticks must not be used on multiple patients
  • Infection control policies and procedures for blood glucose monitoring should be based upon manufacturer’s instructions for use.
  • There should be ongoing monitoring of compliance with infection control processes for blood glucose monitoring, equipment cleaning and disinfecting.
  • Glucometers and/or other waived testing devices must be approved for use on multiple patients and must be cleaned and disinfected after each test, per manufacturer instruction.
  • Staff should be trained and assessed in the use of blood glucose monitoring equipment
  • Staff should be educated on the infection control risks associated with the use of lancets, fingerstick devices and glucometers

Included with today’s notice is an example policy related to the use of blood glucose monitoring equipment.

Want to read the full alert and receive alert emails?

Browse Additional Alerts